Home » Topics » Regulatory

Regulatory
RSS

Aplidin approved in Australia for the treatment of multiple myeloma

Dec. 12, 2018

FDA approves Dextenza intracanalicular insert to treat postsurgical ocular pain

Dec. 3, 2018

Precedex approved for use in pediatric patients in Japan

Nov. 30, 2018

Melinta Therapeutics granted marketing authorization for Vabomere in Europe

Nov. 28, 2018

FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion

Nov. 27, 2018

European Commission approves pegfilgrastim biosimilar Pelmeg

Nov. 26, 2018

FDA approves Daurismo for newly diagnosed AML ineligible for intensive chemotherapy

Nov. 22, 2018

FDA grants accelerated approval to Venclexta for newly diagnosed AML

Nov. 22, 2018

FDA approves Gamifant for primary hemophagocytic lymphohistiocytosis

Nov. 21, 2018

FDA approves Aemcolo for the treatment of travelers' diarrhea

Nov. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...